AHR vs. VMRK: American Healthcare REIT vs. Vivmark Residential Stock Comparison

Company Profile

American Healthcare REIT (AHR) and Vivmark Residential (VMRK) both fall under the Equity Real Estate Investment Trusts (REITs) industry group, but AHR is classified in Diversified REITs while VMRK is classified in Residential REITs.

Vivmark Residential (VMRK) carries decades of public-market history since August 12, 1993, while American Healthcare REIT (AHR) listed on February 7, 2024 — long-window comparisons have far more historical data on the VMRK side.

Both American Healthcare REIT (AHR) and Vivmark Residential (VMRK) are REITs — read their payout ratios and P/E alongside FFO (funds from operations) rather than at face value.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both American Healthcare REIT (AHR) at 2.33% and Vivmark Residential (VMRK) at 8.49% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Neither American Healthcare REIT (AHR) in Equity Real Estate Investment Trusts (REITs) nor Vivmark Residential (VMRK) in Equity Real Estate Investment Trusts (REITs) is well served by net margin: heavy depreciation makes net income a poor profitability proxy in their businesses, where FFO-based measures are the standard read.

Neither side reports a meaningful operating margin: for American Healthcare REIT (AHR) in Equity Real Estate Investment Trusts (REITs) and Vivmark Residential (VMRK) in Equity Real Estate Investment Trusts (REITs), funding costs are part of the core business, so net margin and ROE are the cleaner profitability reads.

Profitability Metrics

Growth

Both American Healthcare REIT (AHR) at 9.15% and Vivmark Residential (VMRK) at 4.36% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

EPS growth isn't a meaningful figure for either American Healthcare REIT (AHR) in Equity Real Estate Investment Trusts (REITs) or Vivmark Residential (VMRK) in Equity Real Estate Investment Trusts (REITs) under our convention.

Growth Metrics

Financial Strength

American Healthcare REIT (AHR) at 1.31 keeps current ratio within its industry’s typical mid-range, while Vivmark Residential (VMRK) at 0.35 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for VMRK.

American Healthcare REIT (AHR) at 0.27 keeps leverage in the lower industry quartile, while Vivmark Residential (VMRK) at 0.75 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Vivmark Residential (VMRK) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile American Healthcare REIT (AHR) reports a yield of 1.78%, ranking against industry peers normally.

An earnings-based payout ratio fits neither American Healthcare REIT (AHR) in Equity Real Estate Investment Trusts (REITs) nor Vivmark Residential (VMRK) in Equity Real Estate Investment Trusts (REITs): their distributions are mandated and conventionally measured against FFO, so the accounting-earnings ratio overstates both.

Dividend Metrics

Valuation

P/E ratio is not a meaningful valuation yardstick for either American Healthcare REIT (AHR) in Equity Real Estate Investment Trusts (REITs) or Vivmark Residential (VMRK) in Equity Real Estate Investment Trusts (REITs): depreciation suppresses reported earnings in their businesses, and price-to-FFO is the conventional yardstick instead.

American Healthcare REIT (AHR) at 5.01 prices around its industry’s typical P/S ratio, while Vivmark Residential (VMRK) at 16.40 clears its benchmark range — VMRK looks notably rich on sales.

A book-value read is available on one side only: American Healthcare REIT (AHR) trades at 2.42 times book with peers to rank against, while Vivmark Residential (VMRK) reports no P/B ratio this period.

Valuation Metrics